Search clinical trials for: PEG-IFNα

Total 7122 results

Vanderbilt University

Recruiting

Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

Peripheral Nerve Injury

United States
Merck Sharp & Dohme LLC

Completed

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

HIV Infections | Hepatitis C | Chronic Hepatitis C
Janssen Infectious Diseases BVBA
Vertex Pharmaceuticals Incorporated

Completed

VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo

Hepatitis C, Chronic

United States, Australia, United Kingdom, Germany, France, Spain, Belgium, Netherlands, Canada, Brazil, Puerto Rico, Poland, Sweden, Switzerland, Israel
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

Hepatitis C
Northwestern University
National Cancer Institute (NCI)

Terminated

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Lymphoma

United States
Air Force Military Medical University, China

Unknown

Comparison of Two Methods for Bowel Preparation in Patients With Constipation

Health Behavior

China
Kansas City Veteran Affairs Medical Center

Completed

Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure (PEG)

Gastrostomy | Head and Neck Neoplasm | Esophageal Stenosis and Obstruction

United States
BioMarin Pharmaceutical

Completed

Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria

Phenylketonuria

United States
GeneScience Pharmaceuticals Co., Ltd.
Children's Hospital of Fudan University; The First Hospital of Jilin University and other collaborators

Unknown

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Small for Gestational Age Infant

China
Merck Sharp & Dohme LLC

Completed

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC

Completed

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)

Hepatitis C, Chronic
Hoffmann-La Roche

Active, not recruiting

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B (Piranga)

Hepatitis B, Chronic

Taiwan, Canada, Korea, Republic of, Thailand, United Kingdom, China, United States, Bulgaria, Spain, New Zealand, Hong Kong, Romania, Chile, France
Hospices Civils de Lyon

Recruiting

Pitch Perception and Memory: Deficits and Training (Pitch_Train)

Cochlear Implants

France
Merck Sharp & Dohme LLC

Completed

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

Hepatitis C, Chronic
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

1L- vs. 4L-PEG for Bowel Preparation Among Inpatients.

Colonoscopy | Bowel Preparation | Hospitalized Patients

Italy
Hoffmann-La Roche

Completed

Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

Hepatitis C, Chronic

Brazil
Jiang Wu

Terminated

Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction

Breast Neoplasms

China
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Pediatric Growth Hormone Deficiency (PGHD)

China
Children's Hospital of Fudan University
RenJi Hospital; Shanghai Children's Hospital; Shanghai Children's Medical Center...

Terminated

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

COVID-19 | Children

China
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy (BOLERO-CB)

Hepatitis C, Chronic

Taiwan
Hoffmann-La Roche

Completed

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Hepatitis C, Chronic

Belgium, United States, Germany, Canada, Austria, Switzerland, Puerto Rico, Australia, Brazil, Mexico
Louis Stokes VA Medical Center

Completed

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir

Hepatitis C, Chronic | Cirrhosis

United States
Children's Hospital of Fudan University

Completed

Efficacy, Safety and Tolerability of Different Bowel Preparation Before Colonoscopy in Children Over 2 Years Old

Bowel Preparation | Child Obesity

China
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

Hepatitis C
Devirex AG

Terminated

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

Genital Herpes

Switzerland
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059) (START 4)

Hepatitis C, Chronic
Hoffmann-La Roche
Roche Pharma AG

Completed

Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Germany
Sun Yat-sen University

Recruiting

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

PD-1 Inhibitor | Granulocyte Colony-Stimulating Factor

China
Tongji Hospital
GeneScience Pharmaceuticals Co., Ltd.

Recruiting

A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

Growth Hormone Treatment | Small for Gestational Age Infant | Cognitive Developmental Disorder

China
Shandong University

Terminated

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Ovarian Neoplasms | Ovarian Cancer | Adjuvant Chemotherapy

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Unknown

Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients

Elderly Lymphoma Patients

China
Anhui Provincial Hospital

Unknown

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

Chemotherapy-induced Neutropenia

China
wang shusen

Unknown

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Breast Cancer

China
Johns Hopkins University

Terminated

Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT

Feeding Tube

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

Acute Lymphoid Leukemia

China
Peking University

Unknown

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Lymphoma | Mammary Cancer | Bone Tumour | Gynecological Tumors

China
FDA Office of Orphan Products Development

Completed

Testing of ADI-PEG in Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
PharmAthene, Inc.
United States Department of Defense; Quintiles, Inc.; QPS Holdings LLC

Completed

First Time in Human Study of Protexia

Intervention for Nerve Agent Exposure

United States
Boston Children's Hospital

Unknown

Multi-modal Neuroimaging in Children With Cerebral Palsy or Brachial Plexus Birth Palsy

Cerebral Palsy | Brachial Plexus; Injury, Newborn

United States
University of Waterloo

Completed

Ocular Effects of Scleral Lens Wear on Dry Eye Patients

Dry Eye

Canada
BioMarin Pharmaceutical

Completed

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Phenylketonuria

United States
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy

Small Cell Lung Cancer | PEG-rhG-CSF

China
Boehringer Ingelheim

Completed

Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects

Healthy
EnzymeRx

Unknown

Safety and Efficacy Study of Intramuscular Uricase-PEG 20

Hyperuricemia | Gout

United States
Huashan Hospital

Not yet recruiting

Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

Chronic Hepatitis B
Postgraduate Institute of Medical Education and...

Unknown

PEG3350 in ACLF With Hepatic Encephalopathy

Acute-On-Chronic Liver Failure | Hepatic Encephalopathy

India
French Innovative Leukemia Organisation

Completed

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)

Myelofibrosis

France
Hoffmann-La Roche

Completed

A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Hepatitis C, Chronic

Australia, Canada, Mexico, New Zealand, Thailand, Argentina
Tibotec BVBA
Tibotec Pharmaceutical Limited

Completed

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Hepatitis C, Chronic

United States, Australia, France, United Kingdom, Germany, Spain, Belgium, Israel, Canada, Brazil, Austria, Poland, Netherlands, Sweden, Switzerland, Puerto Rico

Search clinical trials for: PEG-IFNα

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations